<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005154A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005154</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14019019</doc-number><date>20130905</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><priority-claims><priority-claim sequence="01" kind="regional"><country>EP</country><doc-number>06112779</doc-number><date>20060419</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>5377</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>45</main-group><subgroup>06</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>519</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>5377</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>519</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>45</main-group><subgroup>06</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514171</main-classification><further-classification>51425216</further-classification><further-classification>5142342</further-classification><further-classification>51421018</further-classification><further-classification>51425211</further-classification></classification-national><invention-title id="d0e61">6,7-Dihydrothieno[3,2-d]pyrimidine for the Treatment of Inflammatory Diseases</invention-title><us-related-documents><division><relation><parent-doc><document-id><country>US</country><doc-number>13343391</doc-number><date>20120104</date></document-id><parent-status>PENDING</parent-status></parent-doc><child-doc><document-id><country>US</country><doc-number>14019019</doc-number></document-id></child-doc></relation></division><division><relation><parent-doc><document-id><country>US</country><doc-number>11736703</doc-number><date>20070418</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8114878</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13343391</doc-number></document-id></child-doc></relation></division></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>POUZET</last-name><first-name>Pascale</first-name><address><city>Biberach</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>HOENKE</last-name><first-name>Christoph</first-name><address><city>Ingelheim</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>GOEGGEL</last-name><first-name>Rolf</first-name><address><city>Biberach</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>JUNG</last-name><first-name>Birgit</first-name><address><city>Laupheim</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>NICKOLAUS</last-name><first-name>Peter</first-name><address><city>Warthausen</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="05" app-type="applicant" designation="us-only"><addressbook><last-name>FIEGEN</last-name><first-name>Dennis</first-name><address><city>Biberach</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="06" app-type="applicant" designation="us-only"><addressbook><last-name>FOX</last-name><first-name>Thomas</first-name><address><city>Biberach</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>POUZET</last-name><first-name>Pascale</first-name><address><city>Biberach</city><country>DE</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>HOENKE</last-name><first-name>Christoph</first-name><address><city>Ingelheim</city><country>DE</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>GOEGGEL</last-name><first-name>Rolf</first-name><address><city>Biberach</city><country>DE</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>JUNG</last-name><first-name>Birgit</first-name><address><city>Laupheim</city><country>DE</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>NICKOLAUS</last-name><first-name>Peter</first-name><address><city>Warthausen</city><country>DE</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>FIEGEN</last-name><first-name>Dennis</first-name><address><city>Biberach</city><country>DE</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>FOX</last-name><first-name>Thomas</first-name><address><city>Biberach</city><country>DE</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>BOEHRINGER INGELHEIM INTERNATIONAL GMBH</orgname><role>03</role><address><city>Ingelheim am Rhein</city><country>DE</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The invention relates to new dihydrothienopyrimidine of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof,</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="39.12mm" wi="66.04mm" file="US20140005154A1-20140102-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry></p><p id="p-0003" num="0000">wherein X is SO or SO<sub>2</sub>, but preferably SO, and wherein R<sup>1</sup>, R<sup>2 </sup>and R<sup>3 </sup>have the meanings given in the description,<br/>and which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.</p></abstract></us-patent-application>